VOC (Voice Of Customer)

Breast Cancer (BC)

Please enable JavaScript in your browser to complete this form.
Step 1 of 4

Section A: Introduction

Purpose: We aim to understand perceptions of brands and companies in your field through a 25- 30-minute survey. This market research is sponsored by a healthcare company and follows international guidelines. Your information will be treated confidentially, no personal details will be shared and the data is collected and presented as an aggregate.
Adverse Events:
If you report an adverse event or product complaint in this survey, we will need to report it, even if you've already done so directly. The adverse event data may be processed outside your country, but it will be sent anonymously to our client's pharmacovigilance department. Any further requests will come through the recruiting agency.

Section B: Company Services Evaluation

NPS Assessment & partnership

B1 - On a scale of 1 to 10, how likely are you to recommend collaborating with the following pharmaceutical companies to your colleagues in the same field?
12345678910
Roche
1
2
3
4
5
6
7
8
9
10
Novartis
1
2
3
4
5
6
7
8
9
10
AstraZeneca
1
2
3
4
5
6
7
8
9
10
Amgen
1
2
3
4
5
6
7
8
9
10
Mylan
1
2
3
4
5
6
7
8
9
10
Pfizer
1
2
3
4
5
6
7
8
9
10

Company and Representative Equity

B2 - Please rate the importance of the following attributes of your overall satisfaction with the performance of pharmaceutical companies and their representatives on a scale of 1 to 7, where 1 is "Not at All Important" and 7 is "Extremely Important."
1234567
Provides valuable information at major conferences focused on Breast Cancer (BC) treatments
1
2
3
4
5
6
7
Provides useful educational materials/programs for physicians
1
2
3
4
5
6
7
Provides useful educational materials/programs for other HCPs (Nurses, lab technicians & Physiotherapists, etc.)
1
2
3
4
5
6
7
Commits to supporting and partnering with healthcare professionals in the long-term
1
2
3
4
5
6
7
Organizes continuous and impactful events for physicians
1
2
3
4
5
6
7
Is a leading company in the field of Breast Cancer (BC) treatments
1
2
3
4
5
6
7
Most innovative / Digitalized company Breast Cancer (BC)
1
2
3
4
5
6
7
Organizes medical education (CME)/Seminars for physicians
1
2
3
4
5
6
7
B3 - For each of the following Companies, from whom you receive communication / product specialist visits about Breast Cancer (BC)treatments in particular, we would like to understand how each company performs against each of the following attributes. Please use a 7-point scale where “1” means “Poor performance” and “7’ means “Excellent performance”
1- Provides valuable information at major conferences focused on Breast Cancer (BC) treatments
1234567
Roche
1
2
3
4
5
6
7
Novartis
1
2
3
4
5
6
7
AstraZeneca
1
2
3
4
5
6
7
Amgen
1
2
3
4
5
6
7
Mylan
1
2
3
4
5
6
7
Pfizer
1
2
3
4
5
6
7
2- Provides useful educational materials/programs for physicians
1234567
Roche
1
2
3
4
5
6
7
Novartis
1
2
3
4
5
6
7
AstraZeneca
1
2
3
4
5
6
7
Amgen
1
2
3
4
5
6
7
Mylan
1
2
3
4
5
6
7
Pfizer
1
2
3
4
5
6
7
3- Provides useful educational materials/programs for other HCPs (Nurses, lab technicians & Physiotherapists, etc.)
1234567
Roche
1
2
3
4
5
6
7
Novartis
1
2
3
4
5
6
7
AstraZeneca
1
2
3
4
5
6
7
Amgen
1
2
3
4
5
6
7
Mylan
1
2
3
4
5
6
7
Pfizer
1
2
3
4
5
6
7
4- Commits to supporting and partnering with healthcare professionals in the long-term
1234567
Roche
1
2
3
4
5
6
7
Novartis
1
2
3
4
5
6
7
AstraZeneca
1
2
3
4
5
6
7
Amgen
1
2
3
4
5
6
7
Mylan
1
2
3
4
5
6
7
Pfizer
1
2
3
4
5
6
7
5- Organizes continuous and impactful events for physicians
1234567
Roche
1
2
3
4
5
6
7
Novartis
1
2
3
4
5
6
7
AstraZeneca
1
2
3
4
5
6
7
Amgen
1
2
3
4
5
6
7
Mylan
1
2
3
4
5
6
7
Pfizer
1
2
3
4
5
6
7
6- Is a leading company in the field of Breast Cancer (BC) treatments
1234567
Roche
1
2
3
4
5
6
7
Novartis
1
2
3
4
5
6
7
AstraZeneca
1
2
3
4
5
6
7
Amgen
1
2
3
4
5
6
7
Mylan
1
2
3
4
5
6
7
Pfizer
1
2
3
4
5
6
7
7- Most innovative / Digitalized company Breast Cancer (BC)
1234567
Roche
1
2
3
4
5
6
7
Novartis
1
2
3
4
5
6
7
AstraZeneca
1
2
3
4
5
6
7
Amgen
1
2
3
4
5
6
7
Mylan
1
2
3
4
5
6
7
Pfizer
1
2
3
4
5
6
7
8- Organizes medical education (CME)/Seminars for physicians
1234567
Roche
1
2
3
4
5
6
7
Novartis
1
2
3
4
5
6
7
AstraZeneca
1
2
3
4
5
6
7
Amgen
1
2
3
4
5
6
7
Mylan
1
2
3
4
5
6
7
Pfizer
1
2
3
4
5
6
7

Customer Centricity & Experience

B4 - Please rate the importance of the following attributes related to companies' behaviors towards you and patients on a scale of 1 to 7, where 1 is "Not at All Important" and 7 is "Extremely Important":
1234567
Facilitates patient access to products
1
2
3
4
5
6
7
Provides useful educational materials/programs for patients
1
2
3
4
5
6
7
Supports patients through affordability programs
1
2
3
4
5
6
7
Offers support programs to improve patient experience (e.g., free psychiatry sessions for Breast Cancer (BC) patients)
1
2
3
4
5
6
7
Collaborates with me throughout the treatment journey of my patients
1
2
3
4
5
6
7
Develops well-integrated digital solutions that assist at every step of the patient journey
1
2
3
4
5
6
7
Focuses on and addresses pain points/gaps that patients may experience
1
2
3
4
5
6
7
Listens to feedback and responds quickly, effectively, and accurately
1
2
3
4
5
6
7
Provides content with sufficient details
1
2
3
4
5
6
7
Ensures the content provided is relevant to the therapy areas
1
2
3
4
5
6
7

All rights reserved